This inventor holds 16 USPTO granted patents and 12 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignee: Epizyme, Inc.. Active years: 2014-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Weymouth, MA (US) (2014 - 2016)
- Waban, MA (US) (2016 - 2023)
Company Filing History:
Years Active: 2014-2024
Title: Christine Klaus: Innovator in Pharmaceutical Chemistry
Introduction
Christine Klaus, based in Waban, MA, is a notable inventor recognized for her contributions to the field of pharmaceutical chemistry. With an impressive portfolio of 16 patents, she has made significant strides in the development of innovative compounds aimed at treating serious health conditions such as cancer.
Latest Patents
Among her latest innovations are patents concerning aryl- or heteroaryl-substituted benzene compounds. These compounds play a critical role in pharmaceutical compositions designed for cancer treatment. The inventions not only detail the compounds themselves but also outline methods for administering these compositions to individuals in need. Additionally, Claudia’s research includes the utilization of these compounds for non-therapeutic purposes, showcasing the versatility and significance of her work.
Career Highlights
Christine Klaus has established her career at Epizyme, Inc., a company dedicated to developing innovative therapies for cancer and other diseases. Her role has solidified her status as a key figure in the pharmaceutical industry, contributing valuable insights and advancements through her innovative inventions.
Collaborations
Throughout her career, Klaus has collaborated with talented professionals including Kenneth William Duncan and Kevin Wayne Kuntz. These collaborations have enriched her research, fostering an environment of shared knowledge and driving the advancement of their collective work in pharmaceutical innovations.
Conclusion
Christine Klaus stands out as a prominent inventor in the realm of pharmaceutical chemistry, with a focus on compounds that promise to make an impact in cancer treatment. Her ongoing work at Epizyme, Inc., along with her valuable collaborations, demonstrates her commitment to innovation and improving healthcare through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile